PHAT icon

Phathom Pharmaceuticals

40 hedge funds and large institutions have $677M invested in Phathom Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+40
Holders Change %
% of All Funds
0.79%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.1%
New
40
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$234K +$234K +7,528 New
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$218K +$218K +6,986 New
AIG
28
American International Group
New York
$210K +$210K +6,738 New
Goldman Sachs
29
Goldman Sachs
New York
$202K +$202K +6,492 New
Deutsche Bank
30
Deutsche Bank
Germany
$121K +$121K +3,926 New
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$109K +$109K +3,509 New
SO
32
STRS Ohio
Ohio
$87K +$87K +2,800 New
Citigroup
33
Citigroup
New York
$67K +$67K +2,158 New
Legal & General Group
34
Legal & General Group
United Kingdom
$66K +$66K +2,117 New
Bank of America
35
Bank of America
North Carolina
$58K +$58K +1,855 New
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$42K +$42K +1,352 New
AIP
37
Ameritas Investment Partners
Nebraska
$29K +$29K +925 New
Wells Fargo
38
Wells Fargo
California
$27K +$27K +876 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$22K +$22K +693 New
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$3K +$3K +85 New